Restless Legs Syndrome  >>  ropinirole IR  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ropinirole IR / Generic mfg.
NCT00674310: A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions

Completed
N/A
29
NA
Ropinirole Hydrochloride
Roxane Laboratories
Parkinson's Disease, Restless Leg Syndrome
02/04
02/04
NCT00673088: A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions

Completed
N/A
30
NA
Ropinirole Hydrochloride
Roxane Laboratories
Parkinson's Disease, Restless Leg Syndrome
02/04
02/04
NCT00051961: Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome

Completed
N/A
90
US
National Institute of Neurological Disorders and Stroke (NINDS)
Restless Legs Syndrome
 
10/07
REQUIP RLS PMS, NCT01327339: REQUIP RLS Post Marketing Surveillance

Completed
N/A
755
NA
Ropinirole
GlaxoSmithKline
Restless Legs Syndrome
11/09
11/09

Download Options